YUKIO NAKAMURA; TAKAKO SUZUKI; HIDESHI YAMAZAKI; HIROYUKI KATO. Tofacitinib Versus Non-Tumor Necrosis Factor Biologics for Patients With Active Rheumatoid Arthritis. Archives of Rheumatology, [S. l.], v. 33, n. 2, p. 154–159, 2018. DOI: 10.5606/ArchRheumatol.2018.6366. Disponível em: https://www.archivesofrheumatology.org/index.php/pub/article/view/927. Acesso em: 19 oct. 2025.